Combining keratinocyte growth factor transfection into the airways and tracheal occlusion in a fetal sheep model of congenital diaphragmatic hernia

Journal of Gene Medicine

Volumn 12, Issue 5, 2010, Pages 413-422

  Saada, Julien ^a   Oudrhiri, Noufissa ^a   Bonnard, Arnaud ^a   De Lagausie, Pascal ^a   Aissaoui, Abderrahim ^a   Hauchecorne, Michelle ^a   Oury, Jean François ^a   Aigrain, Yves ^a   Peuchmaur, Michel ^a   Lehn, Jean Marie ^b   Lehn, Pierre ^a,c   Luton, Dominique ^a,d  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^d BEAUJON HOSPITAL   (France)

Author keywords

BGTC; Congenital diaphragmatic hernia; Fetal gene therapy; Fetal sheep; In utero; KGF; Transfection

Indexed keywords

BISGUANIDINIUMTREN CHOLESTEROL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; GUANIDINE DERIVATIVE; KERATINOCYTE GROWTH FACTOR; LUNG SURFACTANT; SURFACTANT PROTEIN B; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CELL MATURATION; CELL PROLIFERATION; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; FETUS; FETUS LUNG MATURATION; GENETIC TRANSFECTION; LAMB; LUNG ALVEOLUS CELL TYPE 2; LUNG DEVELOPMENT; LUNG FUNCTION; LUNG HYPOPLASIA; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SHEEP; TRACHEA OBSTRUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; FETUS; FIBROBLAST GROWTH FACTOR 7; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HERNIA, DIAPHRAGMATIC; LUNG; ORGAN SIZE; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP; TRACHEA; TRANSFECTION;

OVIS; OVIS ARIES;

EID: 77952575684     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1451     Document Type: Article

References (60)

1. Smith NP, Jesudason EC, Losty PD. Congenital diaphragmatic hernia. Pediatr Respir Rev 2002; 3: 339-348.
2. Benachi A, Chailley-Heu Y, Delezoide AL, et al. Lung growth and maturation after tracheal occlusion in diaphragmatic hernia. Am J Crit Care Med 1998; 157: 921-927. (Pubitemid 28150710)
3. Joe P, Wallen LD, Chapin CJ, et al. Effects of mechanical factors on growth and maturation of the lung in fetal sheep. Am J Physiol 1997; 272: L95-L105. (Pubitemid 27073949)
4. Kitano Y, Kanai M, Davies P, et al. Lung growth induced by prenatal tracheal occlusion and its modifying factors: a study in the rat model of congenital diaphragmatic hernia. J Pediatr Surg 2001; 36: 1845-1848.
5. De Paepe M, Papadakis K, Luks FI. Fetal tracheal ligation: fate of the type II pneumocyte. Lab Invest 1996; 74: 162 A.
6. Chelly N, Mouhieddine-Gueddiche OB, Barlier-Mur AM, Chailley-Heu B, Bourbon J. Keratinocyte growth factor enhances maturation of fetal rat lung type II cells. Am J Respir Cell Mol Biol 1999; 20: 423-432. (Pubitemid 129504864)
7. Yano T, Mason RJ, Pan T, Deterding RR, Nielsen LD, Shannon JM. KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Am J Physiol lung Cell Mol Physiol 2000; 279: L1146-L1158. (Pubitemid 32009501)
8. Mason RJ, Lewis MC, Edeen KE, McCormick-Shannon K, Nielsen LD, Shannon JM. Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro. Am J Physiol Lung Cell Mol Physiol 2002; 282: L249-L258. (Pubitemid 34654676)
9. Ulich TR, Yi ES, Longmuir K, et al. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 1994; 93: 1298-1306. (Pubitemid 24087188)
10. McCabe AJ, Carlino U, Holm BA, Glick PL. Upregulation of Keratinocyte Growth Factor in the tracheal ligation lamb model of congenital diaphragmatic hernia. J Pediatr Surg 2001; 36: 128-132.
11. Teramoto H, Yonedo A, Puri P. Gene expression of fibroblast growth factors 10 and 7 is downregulated in the lung of nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg 2003; 38: 1021-1024. (Pubitemid 36828866)
12. Coutelle C, Themis M, Waddington S, et al. The hopes and fears of in utero gene therapy for genetic diseases - a review. Placenta 2003; 24: S114-S121.
13. Coutelle C, Themis M, Waddington SN, et al. Gene therapy progress and prospects: fetal gene therapy - first proofs of concept- some adverse effects. Gene Ther 2005; 12: 1601-1607.
14. David AL, Peebles D. Gene therapy for the fetus: is there a future? Best Pract Res Clin Obstet Gynaecol 2008; 22: 203-218.
15. Coutelle C. Why bother? Is in utero gene therapy worth the effort? Mol Ther 2008; 16: 219-220.
16. Wagner AM, Schoeberlein A, Surbek D. Fetal gene therapy: opportunities and risks. Adv Drug Deliv Rev 2009; 61: 813-821.
17. Mason CA, Bigras JL, O'Blenes SB, et al. Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin-dependent neointimal formation. Nat Med 1999; 5: 176-182.
18. Holzinger A, Trapnell BC, Weaver TE,Whitsett JA, Iwamoto HS. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr Res 1995; 38: 844-850.
19. Sekhon HS, Larson JE. In utero gene transfer into the pulmonary epithelium. Nat Med 1995; 1: 1201-1203.
20. Douar AM, Adebakin S, Themis M, Pavirani A, Cook T, Coutelle C. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther 1997; 4: 883-890. (Pubitemid 27437713)
21. Iwamoto HS, Trapnell BC, McConnell CJ, Daugherty C, Whitsett JA. Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther 1999; 6: 98-106.
22. Schneider H, Adebakin S, Themis M, et al. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. J Gene Med 1999; 1: 424-432. (Pubitemid 129631284)
23. Larson JE, Morrow SL, Delcarpio JB, et al. Gene transfer into the fetal primate: evidence for the secretion of transgene product. Mol Ther 2000; 2: 631-639.
24. Boyle MP, Enke RA, Adams RJ, Guggino WB, Zeitlin PL. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol Ther 2001; 4: 115-121.
25. McCray PB Jr, Armstrong K, Zabner J, et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 1995; 95: 2620-2632.
26. Pitt BR, Schwarz MA, Pilewski JM, et al. Retrovirus-mediated gene transfer in lungs of living fetal sheep. Gene Ther 1995; 2: 344-350.
27. Vincent MC, Trapnell BC, Baughman RP, Wert SE, Whitsett JA, Iwamoto HS. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6: 1019-1028.
28. Sylvester KG, Yang EY, Cass DL, Crombleholme TM, Adzick NS. Fetoscopic gene therapy for congenital lung disease. J Pediatr Surg 1997; 32: 964-969.
29. Peebles D, Gregory LG, David A, et al. Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero. Gene Ther 2004; 11: 70-78.
30. Luton D, Oudrhiri N, de Lagausie P, et al. Gene transfection into fetal sheep airways in utero using guanidinium-cholesterol cationic lipids. J Gene Med 2004; 6: 328-336.
31. Gill DR, Smyth SE, Goddard CA, et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter. Gene Ther 2001; 8: 1539-1546.
32. Vigneron JP, Oudrhiri N, Fauquet M, et al. Guanidinium-choletserol cationic lipids: efficient vectors for the transfection of eukaryotic cells. Proc Natl Acad Sci USA 1996; 93: 9682-9686.
33. Pitard B, Oudrhiri N, Lambert O, et al. Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo. J Gene Med 2001; 3: 478-487.
34. Emery JL, Mithal A. The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood. Arch Dis Child 1960; 35: 544-547.
35. Larousserie F, Berrebi D, Florentin A, De Lagausie P, Aigrain Y, Peuchmaur M. Down-regulation of CD95 (Fas/Apo-1) in the epithelia of adenovirus-infected appendices. Histopathology 1997; 31: 342-346. (Pubitemid 27448915)
36. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cell. Proc Natl Acad Sci USA 1989; 86: 802-806.
37. Ware LB, Matthay MA. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002; 282: L924-L940.
38. Danilenko DM. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol 1999; 27: 64-71.
39. Shannon JM, Mason RJ, Jennings SD. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cell-cell interactions. Biochim Biophys Acta 1987; 931: 143-156.
40. Rannels SR, Grove RN, Rannels DE. Matrix-derived soluble components influence type II pneumocytes in primary culture. Am J Physiol 1989; 256: C621-C629.
41. Guttierrez JA, Gonzales RF, Dobbs LG. Mechanical distension modulates pulmonary alveolar epithelial phenotupic expression in vitro. Am J Physiol Lung Cell Mol Physiol 1998; 274: L196-L202. (Pubitemid 28140856)
42. Alcorn DA, Adamson TM, Maloney JE, Ritchie BC, Robinson PM. Morphological effects of tracheal ligation and drainage in the fetal lamb lung. J Anat 1977; 3: 649-660.
43. Lipsett J, Cool JC, Runciman SI, Ford WD, Kennedy JD, Martin AJ. Effect of antenatal tracheal occlusion on lung development in the sheep model of congenital diaphragmatic hernia: a morphometric analysis of pulmonary structure and maturity. Pediatr Pulmonol 1998; 25: 257-269.
44. Benachi A, Delezoide AL, Chailley-Heu B, Preece M, Bourbon JR, Ryder T. Ultrastructural evaluation of lung maturation in a sheep model of diaphragmatic hernia and tracheal occlusion. Am J Respir Cell Mol Biol 1999; 20: 805-812. (Pubitemid 129495669)
45. Moreno R, Rosal M, Martinez I, et al. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model. J Gene Med 2008; 10: 951-964.
46. Themis M, Waddington SN, Schmidt M, et al. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 2005; 12: 763-771.
47. Michelson PH, Tigue M, Panos RJ, Sporn PH. Keratinocyte growth factor stimulates bronchial epithelial cell proliferation in vitro and in vivo. Am J Physiol 1999; 277: L737-L742. (Pubitemid 29522639)
48. Morikawa O, Walker TA, Nielsen LD, Pan T, Cook JL, Mason RJ. Effect of adenovector-mediated gene transfer of keratinocyte growth factor on the proliferation of alveolar type II cells in vitro and in vivo. Am J Respir Cell Mol Biol 2000; 23: 626-635.
49. Wild YK, Piasecki GJ, De Paepe ME, Luks FI. Short-term tracheal occlusion in fetal lambs with diaphragmatic hernia improves lung function, even in the absence of lung growth. J Pediatr Surg 2000; 35: 775-779.
50. Harrison MR, Keller LR, Hawgood SB, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med. 2003; 349: 1916-1924.
51. Bétrémieux P, Lionnais S, Beuchée A, et al. Perinatal management and outcome of prenatally diagnosed congenital diaphragmatic hernia: a 1995-2000 series in Rennes University Hospital. Prenat Diagn 2002; 22: 988-994.
52. Skari H, Bjornland K, Haugen G, Egeland T, Emblem R. Congenital diaphragmatic hernia: a meta-analysis of mortality factors. J Pediatr Surg 2000; 35: 1187-1197.
53. Jani J, Gratacos E, Greenough A, et al. Percutaneous fetal endoscopic tracheal occlusion (FETO) for severe left-sided congenital diaphragmatic hernia. Clin Obstet Gynecol 2005; 48: 910-922.
54. Jani JC, Nicolaides KH, Gratacos E, et al. Severe diaphragmatic hernia treated by endoscopic tracheal occlusion. Ultrasound Obstet Gynecol 2009; 34: 304-310.
55. Oswari J, Matthay MA,Margulies SS. Keratinocyte growth factor reduces alveolar epithelial susceptibility to in vitro mechanical deformation. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1068-L1077. (Pubitemid 33116159)
56. Charafeddine L, D'Angio CT, Richards JL, et al. Hyperoxia increases keratinocyte growth factor mRNA expression in neonetal rabbit lung. Am J Physiol Lung Cell Mol Physiol 1999; 276: L105-L113. (Pubitemid 29061671)
57. Ulrich K, Stern M, Goddard ME, et al. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1179-L1192.
58. Larson JE, Cohen JC. Improvement of pulmonary hypoplasia associated with congenital diaphragmatic hernia by in utero CFTR gene therapy. Am J Physiol Lung Cell Mol Physiol 2006; 291: L4-L10.
59. Bourbon JR, Benachi A. CFTR gene therapy, a method to rescue lung hypoplasia in congenital diaphragmatic hernia? Am J Physiol Lung Cell Mol Physiol 2006; 291: L1-L3.
60. Davies LA, Varathalingam A, Painter H, et al. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knock-out mice. Mol Ther 2008; 16: 812-818.